Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
68.55
-0.02 (-0.03%)
At close: Jun 18, 2026, 4:00 PM EDT
68.61
+0.06 (0.09%)
After-hours: Jun 18, 2026, 6:20 PM EDT
Halozyme Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $95 | Buy | Reiterates | $95 | +38.58% | Jun 16, 2026 |
| Goldman Sachs | Goldman Sachs | Sell Maintains $57 | Sell | Maintains | $57 | -16.85% | Jun 15, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $93 | Buy | Maintains | $93 | +35.67% | Jun 15, 2026 |
| Wells Fargo | Wells Fargo | Hold Reiterates $75 | Hold | Reiterates | $75 | +9.41% | Jun 15, 2026 |
Unknown Analyst J.P. Morgan No rating | J.P. Morgan | Hold Maintains $70 | Hold | Maintains | $70 | +2.12% | May 20, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $96 | Buy | Maintains | $96 | +40.04% | May 11, 2026 |
| Benchmark Co. | Benchmark Co. | Buy Maintains $75 → $90 | Buy | Maintains | $75 → $90 | +31.29% | Feb 19, 2026 |
| Leerink Partners | Leerink Partners | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Jan 8, 2026 |